0000950170-23-044389.txt : 20230824 0000950170-23-044389.hdr.sgml : 20230824 20230824162737 ACCESSION NUMBER: 0000950170-23-044389 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230824 DATE AS OF CHANGE: 20230824 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001582313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980661854 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36687 FILM NUMBER: 231202520 BUSINESS ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W BUSINESS PHONE: (604) 484-3300 MAIL ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Svoronos Dawn CENTRAL INDEX KEY: 0001574579 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O MEDIVATION, INC. STREET 2: 525 MARKET ST., 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: Graham Dawn DATE OF NAME CHANGE: 20130416 144 1 primary_doc.xml 144 0001574579 XXXXXXXX LIVE 0001582313 Xenon Pharmaceuticals Inc. 001-36687 200-3650 Gilmore Way Burnaby A1 V5G 4W8 (604)-484-3300 DAWN SVORONOS Director Common Shares TD Wealth / TD Waterhouse

6500 TransCanada Highway Suite 200 Pointe-Claire A8 H9R 0A5

25000 967529 63718350 08/24/2023 NASDAQ Common Shares 08/14/2017 Open market or private purchase of non-derivative or derivative security Open market N 50000 08/14/2017 Cash Y 08/24/2023 Dawn Svoronos